The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
Public ClinicalTrials.gov record NCT03645408. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A double-blind, randomized, placebo-controlled, crossover design trial was used to test the effect of exenatide on alcohol self-administration and craving following a priming dose of alcohol. The specific objective of this research was to determine whether exenatide has effects on alcohol consumption.
Study identification
- NCT ID
- NCT03645408
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 8 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 1, 2019
- Primary completion
- Jun 30, 2021
- Completion
- Jun 30, 2021
- Last update posted
- Feb 8, 2022
2019 – 2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Boston University Psychiatry Research Center, Clinical Studies Unit | Boston | Massachusetts | 02118 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Alcohol Use Disorder trials
Other public records listing Alcohol Use Disorder. Sorted by last update posted; newest first. Not a recommendation.
- NCT07027839: Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B) Recruiting
- NCT05607290: Clinical Course of Alcohol Use Disorder Recovery Active, not recruiting
- NCT07724275: Understanding Pathways to Wellness and Recovery in Detroit - Digital Recovery Support Services Recruiting
- NCT07678567: Pomegranate Dietary Supplements in AUD and ALD Not yet recruiting
- NCT05827159: Emergency Department-Initiated Medications for Alcohol Use Disorder Recruiting
- NCT07713251: Supporting Adolescent Alcohol Treatment With Computer-Based ('Path180') Skills Training Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03645408, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 8, 2022 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03645408 live on ClinicalTrials.gov.